![Hans van Houte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans van Houte
Directeur Financier/CFO chez
NURIX THERAPEUTICS, INC.
Fortune : 667 634 $ au 31/05/2026
Profil
Hans van Houte currently works at Nurix Therapeutics, Inc., as Chief Financial Officer from 2020.
Mr. van Houte also formerly worked at Vertex Pharmaceuticals, Inc., as Chief Accounting Officer, Treasurer & Controller, Emergent Product Development Seattle, as Vice President-Finance & Operations, Igenica Biotherapeutics, Inc., as Chief Financial Officer, and Bionation LLC, as Managing Partner.
Mr. van Houte received his undergraduate degree from Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/05/2026 | 37 592 ( 0,04% ) | 667 634 $ | 31/05/2026 |
Postes actifs de Hans van Houte
| Sociétés | Poste | Début |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Directeur Financier/CFO | 01/03/2016 |
Anciens postes connus de Hans van Houte
| Sociétés | Poste | Fin |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Directeur Financier/CFO | - |
Bionation LLC | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - |
Formation de Hans van Houte
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionation LLC |
